Eligibility Asthma NCT00766090

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00766090
Criteria
Beschreibung

Criteria

clinical diagnosis of asthma
Beschreibung

asthma

Datentyp

boolean

Alias
UMLS CUI [1]
C0004096
reversibility ≥ 12% and ≥200mls reversibility of fev1 within approximately 30-minutes following 2 to 4 puffs of albuterol
Beschreibung

fev1 reversibility after albuterol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0449261
UMLS CUI [2]
C0001927
fev1 between 40-85% predicted
Beschreibung

fev1

Datentyp

boolean

Alias
UMLS CUI [1]
C0748133
currently on short acting beta2 agonist therapy
Beschreibung

short-acting beta-2 agonist

Datentyp

boolean

Alias
UMLS CUI [1]
C1373132
key exclusion criteria:
Beschreibung

exclusion criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
history of life threatening asthma
Beschreibung

history of life threatening asthma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
respiratory infection or oropharyngeal candidiasis
Beschreibung

respiratory infection or oropharyngeal candidiasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0035243
UMLS CUI [2]
C0919659
asthma exacerbation
Beschreibung

asthma exacerbation

Datentyp

boolean

Alias
UMLS CUI [1]
C0349790
uncontrolled disease or clinical abnormality
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
allergies
Beschreibung

allergies

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
taking another investigational medications or other prohibited medications
Beschreibung

another investigational medications or other prohibited medication

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2,1]
C0683610
UMLS CUI [2,2]
C0013227

Ähnliche Modelle

Eligibility Asthma NCT00766090

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00766090
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
asthma
Item
clinical diagnosis of asthma
boolean
C0004096 (UMLS CUI [1])
fev1 reversibility after albuterol
Item
reversibility ≥ 12% and ≥200mls reversibility of fev1 within approximately 30-minutes following 2 to 4 puffs of albuterol
boolean
C0748133 (UMLS CUI [1,1])
C0449261 (UMLS CUI [1,2])
C0001927 (UMLS CUI [2])
fev1
Item
fev1 between 40-85% predicted
boolean
C0748133 (UMLS CUI [1])
short-acting beta-2 agonist
Item
currently on short acting beta2 agonist therapy
boolean
C1373132 (UMLS CUI [1])
exclusion criteria
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
history of life threatening asthma
Item
history of life threatening asthma
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
respiratory infection or oropharyngeal candidiasis
Item
respiratory infection or oropharyngeal candidiasis
boolean
C0035243 (UMLS CUI [1])
C0919659 (UMLS CUI [2])
asthma exacerbation
Item
asthma exacerbation
boolean
C0349790 (UMLS CUI [1])
comorbidity
Item
uncontrolled disease or clinical abnormality
boolean
C0009488 (UMLS CUI [1])
allergies
Item
allergies
boolean
C0020517 (UMLS CUI [1])
another investigational medications or other prohibited medication
Item
taking another investigational medications or other prohibited medications
boolean
C0013230 (UMLS CUI [1])
C0683610 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])